Hemoglobin as a source of iron overload in multiple sclerosis: does multiple sclerosis share risk factors with vascular disorders? (Q57898104)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24504127%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

title

Hemoglobin as a source of iron overload in multiple sclerosis: does multiple sclerosis share risk factors with vascular disorders? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24504127%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24504127%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

George Harauz

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24504127%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

author name string

Vladimir V. Bamm

series ordinal

1

0 references

publication date

7 February 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24504127%20AND%20SRC:MED&resulttype=core&format=json

Cellular and Molecular Life Sciences

7 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24504127%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

volume

71

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24504127%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

page(s)

1789-1798

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24504127%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24504127%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00018-014-1570-y

7 March 2020

exact match

0 references

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Regional variation of multiple sclerosis prevalence in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

The history of multiple sclerosis: the changing frame of the disease over the centuries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Multiple sclerosis is an inflammatory T-cell-mediated autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Gray matter pathology in (chronic) MS: modern views on an early observation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Will the real multiple sclerosis please stand up?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Axonal transection in the lesions of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Multiple sclerosis: an immune or neurodegenerative disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

The molecular basis of neurodegeneration in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Pathology and disease mechanisms in different stages of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Multiple sclerosis: distribution of inflammatory cells in newly forming lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Metabolic injury to axons and myelin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Timing of birth and risk of multiple sclerosis: population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Differential effects of genetic susceptibility factors in males and females with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Data integration and systems biology approaches for biomarker discovery: challenges and opportunities for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

The genetics of multiple sclerosis: an up-to-date review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Genetics of multiple sclerosis: swimming in an ocean of data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Association of smoking with risk of multiple sclerosis: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Epigenetic mechanisms in multiple sclerosis: implications for pathogenesis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Epigenome-wide differences in pathology-free regions of multiple sclerosis-affected brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Environmental triggers of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Viral triggers of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Global map of physical interactions among differentially expressed genes in multiple sclerosis relapses and remissions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

From systems biology to systems biomedicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Genetics and iron in the systems biology of Parkinson's disease and some related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

The hallmarks of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Integrating pathways of Parkinson's disease in a molecular interaction map.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Inflammatory vasculitis in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Perivascular iron deposition and other vascular damage in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Microvascular abnormality in relapsing-remitting multiple sclerosis: perfusion MR imaging findings in normal-appearing white matter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

The big idea: iron-dependent inflammation in venous disease and proposed parallels in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Susceptibility mapping as a means to visualize veins and quantify oxygen saturation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Vascular pathology in multiple sclerosis: mind boosting or myth busting?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Lipidome analysis in multiple sclerosis reveals protein lipoxidative damage as a potential pathogenic mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Increased iron accumulation occurs in the earliest stages of demyelinating disease: an ultra-high field susceptibility mapping study in Clinically Isolated Syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Use of MR venography for characterization of the extracranial venous system in patients with multiple sclerosis and healthy control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Oligodendrocytes and myelination: the role of iron

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Iron efflux from oligodendrocytes is differentially regulated in gray and white matter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Iron efflux from astrocytes plays a role in remyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Pathogenic implications of iron accumulation in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Iron and neurodegeneration in the multiple sclerosis brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Iron chelation and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

How do immune cells support and shape the brain in health, disease, and aging?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Immunologic privilege in the central nervous system and the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Deep gray matter involvement on brain MRI scans is associated with clinical progression in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Polymorphisms in the genes coding for iron binding and transporting proteins are associated with disability, severity, and early progression in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Iron elevations in the aging Parkinsonian brain: a consequence of impaired iron homeostasis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Brain iron accumulation in aging and neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Brain, blood, and iron: perspectives on the roles of erythrocytes and iron in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Mechanisms of neuroprotection by hemopexin: modeling the control of heme and iron homeostasis in brain neurons in inflammatory states

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Neuroprotective multifunctional iron chelators: from redox-sensitive process to novel therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Iron deposition is independent of cellular inflammation in a cerebral model of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Iron in chronic brain disorders: imaging and neurotherapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Iron deposition in multiple sclerosis lesions measured by susceptibility-weighted imaging filtered phase: a case control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Visualizing iron in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Iron content of the pulvinar nucleus of the thalamus is increased in adolescent multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Iron deposition on SWI-filtered phase in the subcortical deep gray matter of patients with clinically isolated syndrome may precede structure-specific atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Susceptibility-weighted imaging in the experimental autoimmune encephalomyelitis model of multiple sclerosis indicates elevated deoxyhemoglobin, iron deposition and demyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Inhibition of autoimmune neuropathological process by treatment with an iron-chelating agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Desferrioxamine suppresses experimental allergic encephalomyelitis induced by MBP in SJL mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Apoferritin attenuates experimental allergic encephalomyelitis in SJL mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Deferiprone, an orally deliverable iron chelator, ameliorates experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Copper/zinc chelation by clioquinol reduces spinal cord white matter damage and behavioral deficits in a murine MOG-induced multiple sclerosis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Oxidized Hemoglobin Is an Endogenous Proinflammatory Agonist That Targets Vascular Endothelial Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Endothelial-cell heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Bilirubin binding to myelin basic protein, histones and its inhibition in vitro of cerebellar protein synthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Red cells, hemoglobin, heme, iron, and atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Unconjugated bilirubin restricts oligodendrocyte differentiation and axonal myelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

CCSVI and MS: no meaning, no fact

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Iron deposition and inflammation in multiple sclerosis. Which one comes first?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

What went wrong? The flawed concept of cerebrospinal venous insufficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Oxidation of low-density lipoprotein by hemoglobin stems from a heme-initiated globin radical: antioxidant role of haptoglobin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Haptoglobin phenotypes differ in their ability to inhibit heme transfer from hemoglobin to LDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Neuroprotective role of haptoglobin after intracerebral hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Haptoglobin: a review of the major allele frequencies worldwide and their association with diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Impairment of blood-cerebrospinal fluid barrier in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Acute-phase proteins investigation based on lectins affinity capture prior to 2-DE separation: application to serum from multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Haptoglobin deficiency facilitates the development of autoimmune inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Hemin toxicity: a preventable source of brain damage following hemorrhagic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Heme-hemopexin complex attenuates neuronal cell death and stroke damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Increased striatal injury and behavioral deficits after intracerebral hemorrhage in hemopexin knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Hemopexin induces neuroprotection in the rat subjected to focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Haemopexin affects iron distribution and ferritin expression in mouse brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

A role for hemopexin in oligodendrocyte differentiation and myelin formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Acute-phase protein hemopexin is a negative regulator of Th17 response and experimental autoimmune encephalomyelitis development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Hypoxia and carbon monoxide in the vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Stress proteins in oligodendrocytes: differential effects of heat shock and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Differential upregulation of heme oxygenase-1 (HSP32) in glial cells after oxidative stress and in demyelinating disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Heme oxygenase-1 and neurodegeneration: expanding frontiers of engagement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Membrane lipid modification by polyunsaturated fatty acids sensitizes oligodendroglial OLN-93 cells against oxidative stress and promotes up-regulation of heme oxygenase-1 (HSP32).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Abnormal iron accumulation is involved in the pathogenesis of the demyelinating dmy rat but not in the hypomyelinating mv rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Vascular aspects of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Underlying cause of death in Danish patients with multiple sclerosis: results from the Danish Multiple Sclerosis Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Trends in survival and cause of death in Danish patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Blood cholesterol and MRI activity in first clinical episode suggestive of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Cardiovascular disease complications in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Traditional cardiovascular risk factors in rheumatoid arthritis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Risk of vascular disease in patients with multiple sclerosis: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Rising prevalence of vascular comorbidities in multiple sclerosis: validation of administrative definitions for diabetes, hypertension, and hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

High risk of cardiovascular diseases after diagnosis of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Haem, haem oxygenase and ferritin in vascular endothelial cell injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Multiple sclerosis and cerebral endothelial dysfunction: Mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Heme amplifies the innate immune response to microbial molecules through spleen tyrosine kinase (Syk)-dependent reactive oxygen species generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Characterization of heme as activator of Toll-like receptor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Reaction of Methæmoglobin with Hydrogen Peroxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1570-Y

Iron toxicity in diseases of aging: Alzheimer's disease, Parkinson's disease and atherosclerosis

21 January 2018

1 reference

12 December 2020

Pathoetiology of multiple sclerosis: are we barking up the wrong tree?

1 reference

12 December 2020

Myelin basic protein binds heme at a specific site near the tryptophan residue

1 reference

12 December 2020

Assessing abnormal iron content in the deep gray matter of patients with multiple sclerosis versus healthy controls

1 reference

12 December 2020

Oligodendrogenesis: the role of iron

1 reference

12 December 2020

Expression of heme oxygenase-1 in atherosclerotic lesions

1 reference

12 December 2020

Iron-deficient mice fail to develop autoimmune encephalomyelitis.

1 reference

12 December 2020

Prelude to the framing of a disease: multiple sclerosis in the period before Charcots Leçons

1 reference

12 December 2020

Multiple sclerosis: autoimmune disease or autoimmune reaction?

1 reference

12 December 2020

Hydrogen peroxide kills Staphylococcus aureus by reacting with staphylococcal iron to form hydroxyl radical

1 reference

12 December 2020

Mineral composition of brains of normal and multiple sclerosis victims

1 reference

12 December 2020

The antioxidant activity of haptoglobin towards haemoglobin-stimulated lipid peroxidation

1 reference

12 December 2020

Systems biology for identification of molecular networks in multiple sclerosis

1 reference

12 December 2020

Iron deposits surrounding multiple sclerosis plaques.

1 reference

12 December 2020

Chronic cerebral spinal venous insufficiency in multiple sclerosis

1 reference

12 December 2020

Iron deposits and multiple sclerosis.

1 reference

12 December 2020

Endothelial cell heme oxygenase and ferritin induction by heme proteins: a possible mechanism limiting shock damage

1 reference

12 December 2020

Russell Brains Review of MS.

1 reference

12 December 2020

Immunology of multiple sclerosis

1 reference

12 December 2020

Iron stores and cerebral veins in MS studied by susceptibility weighted imaging.

1 reference

12 December 2020

Degeneration versus autoimmunity in multiple sclerosis

1 reference

12 December 2020

Biological and clinical significance of haptoglobin polymorphism in humans

1 reference

12 December 2020

10.1007/S00018-014-1570-Y

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24504127%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference